Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $57.25M | $53.70M | $241.65M | $55.26M | $55.60M |
| Selling and Admin Expenses | $12.82M | $11.57M | $54.25M | $12.31M | $13.63M |
| -General & Admin Expense | $12.82M | $11.57M | $54.25M | $12.31M | $13.63M |
| Research & Development | $44.44M | $42.12M | $187.40M | $42.95M | $41.97M |
| Operating Profit | -$57.25M | -$53.70M | -$241.65M | -$55.26M | -$55.60M |
| Net Non-Operating Interest Income (Expense) | $3.65M | $4.10M | $22.21M | $4.62M | $5.09M |
| Non-Operating Interest Income | $3.65M | $4.10M | $22.21M | $4.62M | $5.09M |
| Other Income (Expense) | -$98,000.00 | -$62,000.00 | -$443,000.00 | -$69,000.00 | -$108,000.00 |
| Other Non-Operating Income (Expenses) | -$98,000.00 | -$62,000.00 | -$443,000.00 | -$69,000.00 | -$108,000.00 |
| Pretax Profit | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| Net Profit | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| Profit from Continuing Operations | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| Net Income to Parent Company | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| Net Income to Common Stockholders | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| Basic EPS | -$0.81 | -$0.75 | -$3.36 | -$0.77 | -$0.77 |
| Diluted EPS | -$0.81 | -$0.75 | -$3.36 | -$0.77 | -$0.77 |
| Tax | – | – | $0.00 | – | – |
| Minority Interests | – | – | $0.00 | $0.00 | $0.00 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $363.79M | $402.98M | $448.37M | $448.37M | $484.13M |
| Total Current Assets | $341.97M | $361.41M | $386.76M | $386.76M | $342.24M |
| Cash and Cash Equivalents & Short-Term Investments | $334.54M | $351.89M | $377.90M | $377.90M | $332.60M |
| -Cash and Cash Equivalents | $78.64M | $75.08M | $88.33M | $88.33M | $103.34M |
| -Short Term Investments | $255.90M | $276.80M | $289.56M | $289.56M | $229.26M |
| Other Current Assets | $7.44M | $9.52M | $8.86M | $8.86M | $9.64M |
| Total Non-Current Assets | $21.81M | $41.58M | $61.62M | $61.62M | $141.89M |
| Net PPE | $2.50M | $2.78M | $3.05M | $3.05M | $1.54M |
| -Gross PPE | $2.50M | $2.78M | $4.02M | $4.02M | $1.54M |
| Investments and Advances | $19.02M | $38.50M | $58.27M | $58.27M | $140.00M |
| -Held to Maturity Securities | $19.02M | $38.50M | $58.27M | $58.27M | $140.00M |
| Other Non-Current Assets | $297,000.00 | $297,000.00 | $297,000.00 | $297,000.00 | $361,000.00 |
| Total Liabilities | $42.03M | $36.81M | $39.64M | $39.64M | $32.76M |
| Total Current Liabilities | $40.63M | $35.15M | $37.74M | $37.74M | $32.76M |
| Payables | $10.70M | $8.14M | $9.63M | $9.63M | $6.96M |
| -Accounts Payable | $3.73M | $2.51M | $841,000.00 | $841,000.00 | $1.72M |
| -Other Payable | $6.97M | $5.63M | $8.78M | $8.78M | $5.24M |
| Current Accrued Expenses | $22.80M | $21.94M | $16.39M | $16.39M | $15.72M |
| Short-Term Debt and Capital Lease Obligation | $666,000.00 | $725,000.00 | $780,000.00 | $780,000.00 | $1.19M |
| -Current Capital Lease Obligation | $666,000.00 | $725,000.00 | $780,000.00 | $780,000.00 | $1.19M |
| Other Current Liabilities | $1.53M | $1.35M | $996,000.00 | $996,000.00 | $1.52M |
| Total Non-Current Liabilities | $1.41M | $1.66M | $1.90M | $1.90M | $0.00 |
| Long Term Debt and Capital Lease Obligation | $1.41M | $1.66M | $1.90M | $1.90M | $0.00 |
| -Long Term Capital Lease Obligation | $1.41M | $1.66M | $1.90M | $1.90M | $0.00 |
| Total Equity | $321.75M | $366.17M | $408.73M | $408.73M | $451.37M |
| Stockholders' Equity | $321.75M | $366.17M | $408.73M | $408.73M | $451.37M |
| Capital Stock | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -Common Stock | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.01B | $1.00B | $995.82M | $995.82M | $987.80M |
| Retained Earnings | -$691.48M | -$637.78M | -$588.12M | -$588.12M | -$537.41M |
| Gains/Losses Not Affecting Retained Earnings | -$134,000.00 | $127,000.00 | $1.02M | $1.02M | $973,000.00 |
| -Accumulated Depreciation | – | – | -$969,000.00 | -$969,000.00 | – |
| Minority Interests | – | – | $0.00 | $0.00 | $0.00 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$38.22M | -$46.05M | -$175.75M | -$38.11M | -$36.88M |
| Net cash flow from continuing operations | -$38.22M | -$46.05M | -$175.75M | -$38.11M | -$36.88M |
| Net Income from Continuing Operations | -$53.70M | -$49.66M | -$219.88M | -$50.71M | -$50.61M |
| Depreciation & Depletion & Amortization | $79,000.00 | $79,000.00 | $311,000.00 | $79,000.00 | $79,000.00 |
| Change in Working Capital | $7.51M | -$3.30M | $14.08M | $6.14M | $5.55M |
| -Change in Prepaid Assets | $2.09M | -$662,000.00 | $6.90M | $840,000.00 | $798,000.00 |
| -Change in Payables and Accrued Expense | $5.43M | -$2.64M | $7.19M | $5.30M | $4.75M |
| Net cash flow from investing | $40.68M | $32.41M | $179.99M | $22.39M | $67.39M |
| Net Cash Flow from Continuing Investing Activities | $40.68M | $32.41M | $179.99M | $22.39M | $67.39M |
| Net Investment Purchase and Sale | $40.68M | $32.41M | $180.04M | $22.40M | $67.43M |
| Financing Cash Flow | $1.10M | $380,000.00 | $1.09M | $715,000.00 | $0.00 |
| Net Cash Flow from Continuing Financing Activities | $1.10M | $380,000.00 | $1.09M | $715,000.00 | $0.00 |
| Proceeds from Stock Option Exercised | $1.10M | $380,000.00 | $1.09M | $715,000.00 | $0.00 |
| Ending Cash Balance | $78.64M | $75.08M | $88.33M | $88.33M | $103.34M |
| Net Change in Cash | $3.56M | -$13.25M | $5.33M | -$15.00M | $30.52M |
| Beginning Cash Balance | $75.08M | $88.33M | $83.01M | $103.34M | $72.82M |
| Free Cash Flow | -$38.22M | -$46.05M | -$175.80M | -$38.12M | -$36.92M |
| Net PPE Purchase and Sale | – | – | -$49,000.00 | -$11,000.00 | – |
| Net Common Stock Issuance | – | – | $0.00 | $0.00 | – |
No comments yet — be the first to weigh in on CGEM.